Half-Dose Photodynamic Therapy Recommended in the Management of Central Serous Chorioretinopathy during an Era of Limited Supplies of Verteporfin.

Autor: Aw, Kah Long, McLoughlin, Wesley, Cackett, Peter
Předmět:
Zdroj: Ophthalmologica; 2023, Vol. 246 Issue 1, p68-69, 2p
Abstrakt: In their study, they compare the efficacy of half-fluence photodynamic therapy (PDT) and half-dose PDT on the choroidal structure via perfusion of the retinal plexus and choriocapillaris in eyes with chronic central serous chorioretinopathy (CSCR). Comparison of retinochoroidal vascular and structural changes after half-dose photodynamic therapy versus half-fluence photodynamic therapy based on optical coherence tomography angiography in eyes with chronic central serous chorioretinopathy. [Extracted from the article]
Databáze: Complementary Index
Nepřihlášeným uživatelům se plný text nezobrazuje